leukocytes. Blood 2001;97:2854-62 Bae YS, Park EY, Kim Y, He R, Ye RD, Kwak JY, et al. Novel chemoattractant peptides for human leukocytes. Biochem Pharmacol 2003;66:1841-51 Bae YS, Lee HY, Jo EJ, Kim JI, Kang HK, Ye RD, et al. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol 2004;173: 607-14 Berridge MJ. Inositol trisphosphate and calcium signaling. Nature 1993;361:315-25 Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010;33:657-70 Burnashev N. Calcium permeability of ligand-gated chan- nels. Cell Calcium 1998;24:325-32 Dahlgren C, Karlsson A. Respiratory burst in human neutro- phils. J Immunol Methods 1999;232:3-14 de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol 1996;98:152-64 Dooley CT, Ny P, Bidlack JM, Houghten RA. Selective ligands for the mu, delta, and kappa opioid receptors identified from a single mixture based tetrapeptide positional scanning combinatorial library. J Biol Chem 1998;273:18848-56 Hayashi S, Kurdowska A, Miller EJ, Albright ME, Girten BE, Cohen AB. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils. J Immunol 1995;154:814-24 Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991;354:84-6 Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008;13:2400-7 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50 Kumar V, Sharma A. Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 2010;10:1325-34 Lee HY, Kim SD, Shim JW, Lee SY, Lee H, Cho KH, et al. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J Immunol 2008;181:4332-9 Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-pene- Novel neutrophil-activating peptides 137 trable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem 1997;122:498-505 Noh DY, Shin SH, Rhee SG. Phosphoinositide-specific phospholipase C and mitogenic signaling. Biochim Biophys Acta 1995;1242:99-113 Owens RA, Gesellchen PD, Houchins BJ, DiMarchi RD. The rapid identification of HIV protease inhibitors through the synthesis and screening of defined peptide mixtures. Biochem Biophys Res Commun 1991;181:402-8 Rhee SG. Regulation of phosphoinositide-specific phos- pholipase C. Annu Rev Biochem 2001;70:281-312 Rossi F. The O2- -forming NADPH oxidase of the phago- cytes: nature, mechanisms of activation and function. Biochim Biophys Acta 1986;853:65-89 Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003;170:5268-75 Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 1993;18:43-7 Seo JK, Choi SY, Kim Y, Baek SH, Kim KT, Chae CB, et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 1997;158: 1895-901 Spilberg I, Mehta J, Daughaday C, Simchowitz L. Determination of a specific receptor for formyl-methionyl- leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production. J Lab Clin Med 1981;97:602-9 Tiffany HL, Lavigne MC, Cui YH, Wang JM, Leto TL, Gao JL, et al. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem 2001;276:23645-52 Walther A, Riehemann K, Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell 2000;5: 831-40 Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, et al. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009;61:119-61 Zhu MX, Ma J, Parrington J, Calcraft PJ, Galione A, Evans AM. Calcium signaling via two-pore channels: local or global, that is the question. Am J Physiol Cell Physiol 2010;298: C430-41